ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Thyme Care raised a $125M Series E at a $2B+ valuation. The company focuses on filling gaps in cancer treatment through a virtual navigation platform. The funding round was reported by Ian Thomas of CNBC.
Tap to vote and see what everyone thinks.
Summary by ByteBrief